MONTREAL, QUEBEC--(Marketwire - September 17, 2008) - Ambrilia Biopharma Inc. (TSX: AMB) today announced that Dr. Philippe Calais, President and CEO, will present the Company and its projects at BioContact Quebec 2008 to be held in Quebec City, October 1-3. This presentation will take place on Wednesday, October 1, Laval room (Chateau Frontenac), at 2:00 pm local time.
